Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Chandler Robinson Insider Profile
4 Followers
Chandler Robinson, CEO, Director at Monopar Therapeutics Inc, holds 911.75K shares in Monopar Therapeutics Inc (Ticker: MNPR).
Chandler Robinson has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Chandler Robinson's holdings
Insider Roles
CEO, Director
Roles that Chandler Robinson holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Chandler Robinson
Chandler Robinson's Trading History
List of latest transactions for each holding click on a transaction to see Chandler Robinson's performance on stock
You May Also Like
Chandler Robinson insider profile FAQ
What is the percentage of profitable transactions made by Chandler Robinson?
The percentage of profitable transactions made by Chandler Robinson is ―.
What is the average return per transaction made by Chandler Robinson?
The average return per transaction made by Chandler Robinson is ―.
What stocks does Chandler Robinson hold?
Chandler Robinson holds: MNPR stocks.
What was Chandler Robinson’s latest transaction?
Chandler Robinson latest transaction was an Uninformative Buy of $20.06K.
What was Chandler Robinson's most profitable transaction?
Chandler Robinson’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Chandler Robinson's role in Monopar Therapeutics Inc?
Chandler Robinson's role in Monopar Therapeutics Inc is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.